Advisor Group’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-97
Closed – – 5153
2017
Q2
$0 Buy
97
+40
+70% +$18 ﹤0.01% 5099
2017
Q1
$0 Buy
57
+27
+90% +$10 ﹤0.01% 4983
2016
Q4
$0 Buy
30
+13
+76% +$7 ﹤0.01% 4847
2016
Q3
$0 Sell
17
-4
-19% -$1 ﹤0.01% 4853
2016
Q2
$0 Buy
+21
New +$11 ﹤0.01% 4666

Advisor Group's AST.WS Position: Q3 2017 in Review

Advisor Group sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 97 shares.

Advisor Group first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Advisor Group reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • Advisor Group sold 97 Asterias Biotherapeutics Warrants shares in Q3 2017.
  • Advisor Group first reported a position in Asterias Biotherapeutics Warrants in Q2 2016 and held it in 5 quarters.
  • Advisor Group's Asterias Biotherapeutics Warrants position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on Advisor Group's 13F filing for Q3 2017, filed 6 Nov 2017.